MedTrace Logo

The Changes of Urine Growth Factors Level

NCT06282731 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2024-02-28

No results posted yet for this study

Summary

The Changes of Urine Growth Factors Level in Patients With Benigh Prostate Hyperplasia after medical treatment.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DRUG

Silodosin

Indications:Benign prostate hyperplasia

Sponsors & Collaborators

  • En Chu Kong Hospital

    lead OTHER

Principal Investigators

  • Cheng Cheng Wang, M.D Ph.D · Department of urology,En Chu Nong Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2016-09-01
Completion
2017-04-27

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06282731 on ClinicalTrials.gov